Replies to post #223340 on Amarin Corp Plc (AMRN)

[tmac20]

Marki - nothing would surprise me at this point. Seems like a lot of day trading going on with these wild swings at the start and end.

It's interesting to note that a year ago to the day, this stock was at 22.82 so with all the great earnings reports, ADA, AHA, etc endorsements, increasing scripts, priority review, outstanding ICER report, money in the bank, hiring sales reps, and by all accounts a "shoe in" for the AdCom, … HERE WE SIT 5.34% LOWER after all this great news. Now I know there was no runup prior to the release of the trial data but are people really that stupid to be sitting on the sidelines twice? I hate to say it / think it, but I'm thinking there will be a "gotcha" at the AdCom that delays our happy dance. There will be something. Something like "explain why not 1 left handed person saw a benefit" or something so obscure Amarin will not have an answer for. Too many people want this to fail as a little 1 drug pharma company is about to school the entire industry!

[couldbebetter]

Markipeach, What scares me is upon any expected big news event, Herper,
who now works for Stat, can take any issue and blow it way out of
proportion to allow the short sellers to knock down the price. This
has happened time and time again, over and over again. The only way to
end it will be a takeout of AMRN by BP. Certainly JT is aware of this
and he has stated he will do what is best for shareholders.

What I do not know is why he raised more money then he really needed.
Did he raise excess funds so he can diversify AMRN away from Omega-3's?
Or, did he raise excess funds to insure BP could not bully him into an
inferior takeover offer. Very low risk of a takeover until after the
FDA decides label expansion and the generics settle. After those two
issues are settled either a takeover will happen or else AMRN will do
a distribution deal for Europe.